Basic Information
| RNALocate ID: | RLID:11002363 |
| RNA Symbol: | hsa-miR-299-3p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-299-3p |
| RNA ID: | miRBase:MIMAT0000687 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23663360 |
| Tissue/Cell Line: | Plasma |
| Method: | Next-generation RNA sequencing |
| Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:11002361 | Exosome | Serum | 18589210 |
| RLID:11002362 | Exosome | Brain tissue | 23382797 |
| RLID-D:11000111 | Exosome | Endothelial cells | |
| RLID-D:11000399 | Microvesicle | Blood|Fibroblasts|Mesenchymal stem cells |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-299-3p | Splenic marginal zone lymphoma | MNDR-E-MI-34519 |
| MNDR | hsa-miR-299-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-34520 |
| MNDR | hsa-miR-299-3p | Lymphoma | MNDR-E-MI-34521 |
| MNDR | hsa-miR-299-3p | Lymphoma non-hodgkin | MNDR-E-MI-34522 |
| MNDR | hsa-miR-299-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-34523 |
| MNDR | hsa-miR-299-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-34524 |
| MNDR | hsa-miR-299-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-34525 |
| MNDR | hsa-miR-299-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-34526 |
| MNDR | hsa-miR-299-3p | Her2-receptor positive breast cancer | MNDR-E-MI-34527 |
| MNDR | hsa-miR-299-3p | Breast cancer luminal | MNDR-E-MI-34528 |
| MNDR | hsa-miR-299-3p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-34529 |
| MNDR | hsa-miR-299-3p | Gastric cancer | MNDR-E-MI-34530 |
| MNDR | hsa-miR-299-3p | Alzheimer disease | MNDR-E-MI-34531 |
| MNDR | hsa-miR-299-3p | Duchenne muscular dystrophy | MNDR-E-MI-34532 |
| MNDR | hsa-miR-299-3p | Head and neck cancer | MNDR-E-MI-34533 |
| MNDR | hsa-miR-299-3p | Lung cancer | MNDR-E-MI-34534 |
| MNDR | hsa-miR-299-3p | Parkinson disease | MNDR-E-MI-34535 |
| MNDR | hsa-miR-299-3p | Colon carcinoma | MNDR-E-MI-34536 |
| MNDR | hsa-miR-299-3p | Breast cancer | MNDR-E-MI-34537 |
| MNDR | hsa-miR-299-3p | Neuroendocrine neoplasia | MNDR-E-MI-34538 |
| MNDR | hsa-miR-299-3p | Pancreatic cancer | MNDR-E-MI-34539 |
| MNDR | hsa-miR-299-3p | Melanoma | MNDR-E-MI-34540 |
| MNDR | hsa-miR-299-3p | Nephroblastoma | MNDR-E-MI-34541 |
| MNDR | hsa-miR-299-3p | West nile virus infection | MNDR-E-MI-34542 |
| MNDR | hsa-miR-299-3p | Ovarian cancer | MNDR-E-MI-34543 |
| MNDR | hsa-miR-299-3p | Prostate adenocarcinoma | MNDR-E-MI-34544 |
| MNDR | hsa-miR-299-3p | Glioblastoma | MNDR-E-MI-34545 |
| MNDR | hsa-miR-299-3p | Glioma | MNDR-E-MI-34546 |
| MNDR | hsa-miR-299-3p | Nemaline myopathy | MNDR-E-MI-34547 |
| MNDR | hsa-miR-299-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-34548 |
| MNDR | hsa-miR-299-3p | Temporal lobe epilepsy | MNDR-E-MI-34549 |
| MNDR | hsa-miR-299-3p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-34550 |
| MNDR | hsa-miR-299-3p | Uterine cancer | MNDR-E-MI-34551 |
| MNDR | hsa-miR-299-3p | Cervical squamous cell carcinoma | MNDR-E-MI-34552 |
| MNDR | hsa-miR-299-3p | Bone-invasive pituitary adenoma | MNDR-E-MI-34553 |
| MNDR | hsa-miR-299-3p | Lung squamous cell carcinoma | MNDR-E-MI-34554 |
| MNDR | hsa-miR-299-3p | Ovarian carcinoma | MNDR-E-MI-34555 |
| MNDR | hsa-miR-299-3p | Bladder urothelial carcinoma | MNDR-E-MI-34556 |
| MNDR | hsa-miR-299-3p | Pancreatic adenocarcinoma | MNDR-E-MI-34557 |
| MNDR | hsa-miR-299-3p | Cholangiocarcinoma | MNDR-E-MI-34558 |
| MNDR | hsa-miR-299-3p | Synovial sarcoma | MNDR-E-MI-34559 |
| MNDR | hsa-miR-299-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-34560 |
| MNDR | hsa-miR-299-3p | Hepatocellular carcinoma | MNDR-E-MI-34561 |
| MNDR | hsa-miR-299-3p | Lymphoblastoid | MNDR-E-MI-34562 |
| MNDR | hsa-miR-299-3p | Retinoblastoma | MNDR-E-MI-34563 |
| MNDR | hsa-miR-299-3p | Barrett's adenocarcinoma | MNDR-E-MI-34564 |
| MNDR | hsa-miR-299-3p | Burkitt lymphoma | MNDR-E-MI-34565 |
| MNDR | hsa-miR-299-3p | Tonsil cancer | MNDR-E-MI-34566 |
| MNDR | hsa-miR-299-3p | Colorectal cancer | MNDR-E-MI-34567 |
| MNDR | hsa-miR-299-3p | Multiple myeloma | MNDR-E-MI-34568 |
| MNDR | hsa-miR-299-3p | Acute lymphocytic leukemia | MNDR-E-MI-34569 |
| MNDR | hsa-miR-299-3p | Stroke lacunar | MNDR-E-MI-34570 |
| MNDR | hsa-miR-299-3p | Barrett's carcinogenesis | MNDR-E-MI-34571 |
| MNDR | hsa-miR-299-3p | Breast cancer her3+ negative | MNDR-E-MI-34572 |
| MNDR | hsa-miR-299-3p | HPV | MNDR-E-MI-34573 |
| MNDR | hsa-miR-299-3p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-34574 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABCE1 | Homo sapiens | RR00024335 |
TOP